fepulab Profile Banner
Ferdinando Pucci's Lab Profile
Ferdinando Pucci's Lab

@fepulab

Followers
318
Following
182
Media
13
Statuses
142

Knowledge is the cure

Joined December 2008
Don't wanna be here? Send us removal request.
@fepulab
Ferdinando Pucci's Lab
10 days
Did anyone notice how B cells and monocytes seem to be the MAIN antigen presenting cells physically interacting with BOTH CD4 and CD8 T cell subset? 🤯.
@LabWaggoner
Waggoner Lab
14 days
A cost-effective ultra-high-throughput cytometry-based framework for the detection of physical interactions between cells, along with the characterization of complex cellular landscapes @naturemethods .
Tweet media one
0
0
0
@fepulab
Ferdinando Pucci's Lab
13 days
RT @BcellBruno: Amen!.
0
1
0
@grok
Grok
2 days
What do you want to know?.
93
16
183
@fepulab
Ferdinando Pucci's Lab
13 days
RT @LabWaggoner: Editorial expression of concern @Cancer_Cell .Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tum….
Tweet card summary image
cell.com
(Cancer Cell 26, 707–721; November 10, 2014)
0
3
0
@fepulab
Ferdinando Pucci's Lab
16 days
RT @LabWaggoner: Engineering B cells to treat and study human disease .@NatureBiotech @ScienceRicker .
0
20
0
@fepulab
Ferdinando Pucci's Lab
16 days
RT @LabWaggoner: Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellul….
0
25
0
@fepulab
Ferdinando Pucci's Lab
18 days
RT @LabWaggoner: Preprint: TCR-enriched nanoscale vesicles shed by activated T cells (ectosomes) are transferred to antigen-primed B cells,….
0
27
0
@fepulab
Ferdinando Pucci's Lab
2 months
"We have been living in what many rightly call a golden age of immunology. Immunologists' discoveries are redefining medicine [. ] and creating mechanism-based strategies to treat or prevent these diseases." .
Tweet card summary image
aai.org
During August, AAI is highlighting the importance of vaccination for people of all ages.
0
0
0
@fepulab
Ferdinando Pucci's Lab
2 months
RT @ImmunityCP: Online now: Transcription factor T-bet regulates the maintenance and differentiation potential of lymph node and lung effe….
0
13
0
@fepulab
Ferdinando Pucci's Lab
2 months
Slowly but steadily, who's really in charge of #adaptive #immune responses is emerging. Stay tuned for our take on this in #cancer. #Bcells.JCI - B cells shape naĂŻve CD8 T cell programming
0
0
0
@fepulab
Ferdinando Pucci's Lab
2 months
RT @DrPaulOffit: My response to Secretary Kennedy's statements about me on Fox News today. It's time to set the record straight. https://t….
0
4K
0
@fepulab
Ferdinando Pucci's Lab
3 months
Now this is cool:.
0
0
1
@fepulab
Ferdinando Pucci's Lab
3 months
RT @AldertonBiol: After 18 years as an editor at @NaturePortfolio journals and @ScienceMagazine , I am now a freelance editor. By being a s….
0
23
0
@fepulab
Ferdinando Pucci's Lab
4 months
RT @JoanMonte: Quote of the day: “If you think research is expensive, try disease.” Mary Lasker.
0
1
0
@fepulab
Ferdinando Pucci's Lab
5 months
RT @slavov_n: How did I not think of this ? . So insightful. So specific. Just leverage AI.
Tweet media one
0
44
0
@fepulab
Ferdinando Pucci's Lab
5 months
Is that the new poverty level?.
@MIT
Massachusetts Institute of Technology (MIT)
5 months
Great news! Undergraduates from families earning below $200,000 can attend MIT tuition-free. This initiative will make higher education more accessible to 80% of American families, ensuring that talented students can pursue their dreams without financial barriers.
0
0
0
@fepulab
Ferdinando Pucci's Lab
5 months
RT @Brown_lab1: NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report
0
18
0
@fepulab
Ferdinando Pucci's Lab
6 months
RT @jkagan1: Evidence continues to emerge that CD4 T cells are important for cancer vaccines. New study in human renal cancer shows that >9….
Tweet card summary image
nature.com
Nature - A phase I trial of a neoantigen-targeting personalized cancer vaccine led to durable and polyfunctional T cell responses and antitumour recognition, and was associated with no recurrence...
0
46
0